Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.

Taieb J, Fakih M, Liposits G, Prager GW, Van Cutsem E, Ciardiello F, Amellal N, Calleja E, Liu M, Roby L, Tabernero J, André T

Open source

DOI: 10.3389/fonc.2024.1506075
Published: 2024
Container: Frontiers in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2024.1506075,
  title = {Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.},
  author = {Taieb J and Fakih M and Liposits G and Prager GW and Van Cutsem E and Ciardiello F and Amellal N and Calleja E and Liu M and Roby L and Tabernero J and André T},
  year = {2024},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2024.1506075},
  url = {https://doi.org/10.3389/fonc.2024.1506075}
}

RIS

TY  - JOUR
TI  - Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.
AU  - Taieb J
AU  - Fakih M
AU  - Liposits G
AU  - Prager GW
AU  - Van Cutsem E
AU  - Ciardiello F
AU  - Amellal N
AU  - Calleja E
AU  - Liu M
AU  - Roby L
AU  - Tabernero J
AU  - André T
PY  - 2024
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2024.1506075
UR  - https://doi.org/10.3389/fonc.2024.1506075
ER  -

APA

J, T., M, F., G, L., GW, P., E, V. C., F, C., N, A., E, C., M, L., L, R., J, T., & T, A. (2024). Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.. Frontiers in oncology. https://doi.org/10.3389/fonc.2024.1506075

Source records

pubmed · retrieved 2026-09-27T07:53:58.341Z